Lymph Ii

Echinacea (angustifolia), Collinsonia Canadensis, Phytolacca Decandra, Kali Iodatum, Pinus Sylvestris, Pix Liquida, Ferrum Phosphoricum, Aesculus Hippocastanum, Baryta Carbonica, Berberis Vulgaris, Bufo Rana, Calcarea Carbonica, Calcarea Phosphorica, Causticum, Hepar Sulphuris Calcareum, Kreosotum, Lycopodium Clavatum, Mercurius Solubilis, Natrum Muriaticum, Nitricum Acidum, Phosphorus, Pulsatilla (vulgaris), Silicea, Stellaria Media, Sulphur, Terebinthina, Thuja Occidentalis


Bioactive Nutritional, Inc.
Human Otc Drug
NDC 43857-0478
Lymph Ii also known as Echinacea (angustifolia), Collinsonia Canadensis, Phytolacca Decandra, Kali Iodatum, Pinus Sylvestris, Pix Liquida, Ferrum Phosphoricum, Aesculus Hippocastanum, Baryta Carbonica, Berberis Vulgaris, Bufo Rana, Calcarea Carbonica, Calcarea Phosphorica, Causticum, Hepar Sulphuris Calcareum, Kreosotum, Lycopodium Clavatum, Mercurius Solubilis, Natrum Muriaticum, Nitricum Acidum, Phosphorus, Pulsatilla (vulgaris), Silicea, Stellaria Media, Sulphur, Terebinthina, Thuja Occidentalis is a human otc drug labeled by 'Bioactive Nutritional, Inc.'. National Drug Code (NDC) number for Lymph Ii is 43857-0478. This drug is available in dosage form of Liquid. The names of the active, medicinal ingredients in Lymph Ii drug includes Anemone Pulsatilla - 12 [hp_X]/mL Barium Carbonate - 12 [hp_X]/mL Berberis Vulgaris Root Bark - 12 [hp_X]/mL Bufo Bufo Cutaneous Gland - 12 [hp_X]/mL Calcium Sulfide - 12 [hp_X]/mL Causticum - 12 [hp_X]/mL Collinsonia Canadensis Root - 3 [hp_X]/mL Echinacea Angustifolia - 3 [hp_X]/mL Ferrum Phosphoricum - 8 [hp_X]/mL Horse Chestnut - 12 [hp_X]/mL and more. The currest status of Lymph Ii drug is Active.

Drug Information:

Drug NDC: 43857-0478
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Lymph Ii
Also known as the trade name. It is the name of the product chosen by the labeler.
Proprietary Name Base: Lymph
The base of the Brand/Proprietary name excluding its suffix.
Proprietary Name Suffix: II
A suffix to the proprietary name, a value here should be appended to the ProprietaryName field to obtain the complete name of the product. This suffix is often used to distinguish characteristics of a product such as extended release (“XR”) or sleep aid (“PM”). Although many companies follow certain naming conventions for suffices, there is no recognized standard.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Echinacea (angustifolia), Collinsonia Canadensis, Phytolacca Decandra, Kali Iodatum, Pinus Sylvestris, Pix Liquida, Ferrum Phosphoricum, Aesculus Hippocastanum, Baryta Carbonica, Berberis Vulgaris, Bufo Rana, Calcarea Carbonica, Calcarea Phosphorica, Causticum, Hepar Sulphuris Calcareum, Kreosotum, Lycopodium Clavatum, Mercurius Solubilis, Natrum Muriaticum, Nitricum Acidum, Phosphorus, Pulsatilla (vulgaris), Silicea, Stellaria Media, Sulphur, Terebinthina, Thuja Occidentalis
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Bioactive Nutritional, Inc.
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Liquid
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:ANEMONE PULSATILLA - 12 [hp_X]/mL
BARIUM CARBONATE - 12 [hp_X]/mL
BERBERIS VULGARIS ROOT BARK - 12 [hp_X]/mL
BUFO BUFO CUTANEOUS GLAND - 12 [hp_X]/mL
CALCIUM SULFIDE - 12 [hp_X]/mL
CAUSTICUM - 12 [hp_X]/mL
COLLINSONIA CANADENSIS ROOT - 3 [hp_X]/mL
ECHINACEA ANGUSTIFOLIA - 3 [hp_X]/mL
FERRUM PHOSPHORICUM - 8 [hp_X]/mL
HORSE CHESTNUT - 12 [hp_X]/mL
LYCOPODIUM CLAVATUM SPORE - 12 [hp_X]/mL
MERCURIUS SOLUBILIS - 12 [hp_X]/mL
NITRIC ACID - 12 [hp_X]/mL
OYSTER SHELL CALCIUM CARBONATE, CRUDE - 12 [hp_X]/mL
PHOSPHORUS - 12 [hp_X]/mL
PHYTOLACCA AMERICANA ROOT - 4 [hp_X]/mL
PINE TAR - 6 [hp_X]/mL
PINUS SYLVESTRIS LEAFY TWIG - 6 [hp_X]/mL
POTASSIUM IODIDE - 6 [hp_X]/mL
SILICON DIOXIDE - 12 [hp_X]/mL
SODIUM CHLORIDE - 12 [hp_X]/mL
STELLARIA MEDIA - 12 [hp_X]/mL
SULFUR - 12 [hp_X]/mL
THUJA OCCIDENTALIS LEAFY TWIG - 12 [hp_X]/mL
TRIBASIC CALCIUM PHOSPHATE - 12 [hp_X]/mL
TURPENTINE OIL - 12 [hp_X]/mL
WOOD CREOSOTE - 12 [hp_X]/mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:ORAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 08 May, 2018
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 17 Sep, 2023
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date: 05 May, 2026
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:BioActive Nutritional, Inc.
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UNII:I76KB35JEV
6P669D8HQ8
1TH8Q20J0U
Q59QU6N72Q
1MBW07J51Q
DD5FO1WKFU
O2630F3XDR
VB06AV5US8
91GQH8I5F7
3C18L6RJAZ
C88X29Y479
324Y4038G2
411VRN1TV4
2E32821G6I
27YLU75U4W
11E6VI8VEG
YFH4WC535J
Q1RGP4UB73
1C4QK22F9J
ETJ7Z6XBU4
451W47IQ8X
2H03479QVR
70FD1KFU70
1NT28V9397
91D9GV0Z28
C5H0QJ6V7F
3JYG22FD73
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.
Pharmacologic Class:Blood Coagulation Factor [EPC]
Calcium [CS]
Cations
Divalent [CS]
Increased Coagulation Factor Activity [PE]
These are the reported pharmacological class categories corresponding to the SubstanceNames listed above.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
43857-0478-160 mL in 1 BOTTLE, DROPPER (43857-0478-1)08 May, 201817 Sep, 2023No
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Indications: for temporary relief of glandular swelling with inflammation and induration, glands hot, swollen, painful; scrofulous swelling, axillary glands swollen with soreness of the upper arm and tonsils.

Product Elements:

Lymph ii echinacea (angustifolia), collinsonia canadensis, phytolacca decandra, kali iodatum, pinus sylvestris, pix liquida, ferrum phosphoricum, aesculus hippocastanum, baryta carbonica, berberis vulgaris, bufo rana, calcarea carbonica, calcarea phosphorica, causticum, hepar sulphuris calcareum, kreosotum, lycopodium clavatum, mercurius solubilis, natrum muriaticum, nitricum acidum, phosphorus, pulsatilla (vulgaris), silicea, stellaria media, sulphur, terebinthina, thuja occidentalis echinacea angustifolia echinacea angustifolia collinsonia canadensis root collinsonia canadensis root phytolacca americana root phytolacca americana root potassium iodide iodide ion pinus sylvestris leafy twig pinus sylvestris leafy twig pine tar pine tar ferrum phosphoricum ferrosoferric phosphate horse chestnut horse chestnut barium carbonate barium cation berberis vulgaris root bark berberis vulgaris root bark bufo bufo cutaneous gland bufo bufo cutaneous gland oyster shell calcium carbonate, crude oyster shell calcium carbonate, crude tribasic calcium phosphate calcium cation causticum causticum calcium sulfide calcium sulfide wood creosote wood creosote lycopodium clavatum spore lycopodium clavatum spore mercurius solubilis mercurius solubilis sodium chloride chloride ion nitric acid nitric acid phosphorus phosphorus anemone pulsatilla anemone pulsatilla silicon dioxide silicon dioxide stellaria media stellaria media sulfur sulfur turpentine oil turpentine oil thuja occidentalis leafy twig thuja occidentalis leafy twig water alcohol

Indications and Usage:

Indications: for temporary relief of glandular swelling with inflammation and induration, glands hot, swollen, painful; scrofulous swelling, axillary glands swollen with soreness of the upper arm and tonsils.

Warnings:

Warnings: if pregnant or breast-feeding, ask a health care professional before use. keep out of reach of children. in case of overdose, get medical help or contact a poison control center right away. do not use if tamper evident seal is broken or missing. store in cool, dry place.

Dosage and Administration:

Directions: 10 drops orally, 3 times a day. consult a physician for use in children under 12 years of age.

Package Label Principal Display Panel:

Package label display: bio active nutritional lymph ii homeopathic 2 fl oz (60 ml) lymph ii

Further Questions:

Questions: distributed by: bioactive nutritional, inc. 1803 n. wickham rd. melbourne, fl 32935 bioactivenutritional.com


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.